{
  "ticker": "REGN",
  "last_updated": "2026-01-08T08:41:46.838336",
  "retention_years": 3,
  "count": 13,
  "transactions": [
    {
      "id": 122,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2026-01-02",
      "transaction_shares": "155",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "31007"
    },
    {
      "id": 123,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2026-01-02",
      "transaction_shares": "155",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "1703"
    },
    {
      "id": 124,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "GOLDSTEIN JOSEPH L",
      "reporting_owner_cik": "0001225474",
      "reporting_owner_position": null,
      "transaction_date": "2026-01-02",
      "transaction_shares": "155",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "6703"
    },
    {
      "id": 125,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2026-01-02",
      "transaction_shares": "155",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "17903"
    },
    {
      "id": 126,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "COLES N ANTHONY",
      "reporting_owner_cik": "0001197018",
      "reporting_owner_position": null,
      "transaction_date": "2026-01-02",
      "transaction_shares": "155",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "1714"
    },
    {
      "id": 127,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Schenkein David P",
      "reporting_owner_cik": "0001578200",
      "reporting_owner_position": null,
      "transaction_date": "2026-01-02",
      "transaction_shares": "155",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "603"
    },
    {
      "id": 128,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2026-01-02",
      "transaction_shares": "155",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "1703"
    },
    {
      "id": 129,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Zoghbi Huda Y",
      "reporting_owner_cik": "0001681643",
      "reporting_owner_position": null,
      "transaction_date": "2026-01-02",
      "transaction_shares": "155",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "1703"
    },
    {
      "id": 130,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Guarini Kathryn",
      "reporting_owner_cik": "0001992352",
      "reporting_owner_position": null,
      "transaction_date": "2026-01-02",
      "transaction_shares": "155",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "603"
    },
    {
      "id": 132,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "POON CHRISTINE A",
      "reporting_owner_cik": "0001189014",
      "reporting_owner_position": null,
      "transaction_date": "2026-01-02",
      "transaction_shares": "155",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "5219"
    },
    {
      "id": 133,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Thompson Craig B.",
      "reporting_owner_cik": "0001423419",
      "reporting_owner_position": null,
      "transaction_date": "2026-01-02",
      "transaction_shares": "155",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "775"
    },
    {
      "id": 121,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2025-12-31",
      "transaction_shares": "28570",
      "transaction_price": "0.0",
      "transaction_type": "M",
      "shares_after_transaction": "243093"
    },
    {
      "id": 131,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2025-12-31",
      "transaction_shares": "28570",
      "transaction_price": "0.0",
      "transaction_type": "M",
      "shares_after_transaction": "339030"
    }
  ]
}